These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 23642462)
1. Effect of sertraline on risk of falling in older adults with psychotic depression on olanzapine: results of a randomized placebo-controlled trial. Flint AJ; Iaboni A; Mulsant BH; Rothschild AJ; Whyte EM; Meyers BS; Am J Geriatr Psychiatry; 2014 Apr; 22(4):332-6. PubMed ID: 23642462 [TBL] [Abstract][Full Text] [Related]
2. Effect of Continuing Olanzapine vs Placebo on Relapse Among Patients With Psychotic Depression in Remission: The STOP-PD II Randomized Clinical Trial. Flint AJ; Meyers BS; Rothschild AJ; Whyte EM; Alexopoulos GS; Rudorfer MV; Marino P; Banerjee S; Pollari CD; Wu Y; Voineskos AN; Mulsant BH; JAMA; 2019 Aug; 322(7):622-631. PubMed ID: 31429896 [TBL] [Abstract][Full Text] [Related]
3. A double-blind randomized controlled trial of olanzapine plus sertraline vs olanzapine plus placebo for psychotic depression: the study of pharmacotherapy of psychotic depression (STOP-PD). Meyers BS; Flint AJ; Rothschild AJ; Mulsant BH; Whyte EM; Peasley-Miklus C; Papademetriou E; Leon AC; Heo M; Arch Gen Psychiatry; 2009 Aug; 66(8):838-47. PubMed ID: 19652123 [TBL] [Abstract][Full Text] [Related]
4. Improvement in Depression is Associated with Improvement in Cognition in Late-Life Psychotic Depression. Victoria LW; Whyte EM; Butters MA; Meyers BS; Alexopoulos GS; Mulsant BH; Rothschild AJ; Banerjee S; Flint AJ Am J Geriatr Psychiatry; 2017 Jun; 25(6):672-679. PubMed ID: 28285771 [TBL] [Abstract][Full Text] [Related]
5. Factors associated with non-completion in a double-blind randomized controlled trial of olanzapine plus sertraline versus olanzapine plus placebo for psychotic depression. Weissman J; Flint A; Meyers B; Ghosh S; Mulsant B; Rothschild A; Whyte E; Psychiatry Res; 2012 May; 197(3):221-6. PubMed ID: 22464991 [TBL] [Abstract][Full Text] [Related]
6. Effect of Older vs Younger Age on Anthropometric and Metabolic Variables During Treatment of Psychotic Depression With Sertraline Plus Olanzapine: The STOP-PD II Study. Flint AJ; Rothschild AJ; Whyte EM; Alexopoulos GS; Mulsant BH; Marino P; Banerjee S; Pollari CD; Wu Y; Voineskos AN; Meyers BS; Am J Geriatr Psychiatry; 2021 Jul; 29(7):645-654. PubMed ID: 33268022 [TBL] [Abstract][Full Text] [Related]
7. Impact of prior pharmacotherapy on remission of psychotic depression in a randomized controlled trial. Blumberger DM; Mulsant BH; Emeremni C; Houck P; Andreescu C; Mazumdar S; Whyte E; Rothschild AJ; Flint AJ; Meyers BS J Psychiatr Res; 2011 Jul; 45(7):896-901. PubMed ID: 21300377 [TBL] [Abstract][Full Text] [Related]
17. Sertraline Versus Placebo in Patients with Major Depressive Disorder Undergoing Hemodialysis: A Randomized, Controlled Feasibility Trial. Friedli K; Guirguis A; Almond M; Day C; Chilcot J; Da Silva-Gane M; Davenport A; Fineberg NA; Spencer B; Wellsted D; Farrington K Clin J Am Soc Nephrol; 2017 Feb; 12(2):280-286. PubMed ID: 28126706 [TBL] [Abstract][Full Text] [Related]
18. Genomic Investigation of Remission and Relapse of Psychotic Depression Treated with Sertraline plus Olanzapine: The STOP-PD II Study. Men X; Marshe V; Elsheikh SS; Alexopoulos GS; Marino P; Meyers BS; Mulsant BH; Rothschild AJ; Voineskos AN; Whyte EM; Kennedy JL; Flint AJ; Müller DJ Neuropsychobiology; 2023; 82(3):168-178. PubMed ID: 37015192 [TBL] [Abstract][Full Text] [Related]